Medical & Economical Evaluation of Fenestrated & Branched Stent-grafts to Treat Complex Thoracal Abdominal Aneurysms (Windows2)
Primary Purpose
Aortic Aneurysm
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Endovascular aortic repair
Open surgical repair
Sponsored by
About this trial
This is an interventional treatment trial for Aortic Aneurysm focused on measuring Aorta, Aneurysm, endovascular, stent-graft
Eligibility Criteria
Inclusion Criteria:
The following anatomical inclusion criteria must be met:
- Absence of significant angulations (< 60°) of aorta or of iliac arteries
- Absence of tight stenosis (>70%) of more than one target artery (renal or visceral artery to be perfused from the side holes of the stent-graft)
- Diameter of target arteries over 5 mm
- Iliac and femoral arteries allowing insertion of the delivery system (> 7 mm) or suitable for insertion of an access conduit
Exclusion Criteria:
- Limited expected life expectancy
- Emergency cases
- Refuse to participate to the study
Sites / Locations
- Henri Mondor Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Other
Arm Label
Endovascular therapy branched
Open surgical repair
Arm Description
Endovascular therapy branched or fenestrated stent-graft
Open surgical repair or aortic replacement with revascularization of visceral arteries
Outcomes
Primary Outcome Measures
mortality
Secondary Outcome Measures
complications
Length of Intensive Care Unit (ICU) stay
Length of Hospital stay
Overall cost
Reinterventions
Global survival
Full Information
NCT ID
NCT01354821
First Posted
May 16, 2011
Last Updated
October 29, 2014
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT01354821
Brief Title
Medical & Economical Evaluation of Fenestrated & Branched Stent-grafts to Treat Complex Thoracal Abdominal Aneurysms
Acronym
Windows2
Official Title
Medical & Economical Evaluation of Endovascular Therapy of Complex Thoracal Abdominal Aneurysms (Type 1-3 Thoracal Abdominal Aneurysms) by Fenestrated & Branched Stent-grafts
Study Type
Interventional
2. Study Status
Record Verification Date
October 2014
Overall Recruitment Status
Unknown status
Study Start Date
November 2009 (undefined)
Primary Completion Date
January 2014 (Actual)
Study Completion Date
December 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this study is to prospectively compare the perioperative mortality severe morbidity and the costs of endovascular versus conventional surgical repair of type 1, 2 and 3 thoracal abdominal aortic aneurysms.
Detailed Description
The aim of this study is to prospectively compare the perioperative mortality severe morbidity and the costs of endovascular versus conventional surgical repair of type 1, 2 and 3 thoracal abdominal aortic aneurysms.
The primary goal of the study is to demonstrate a significant drop in 30-day mortality and life threatening morbidity in the endovascular arm of the study. Our hypothesis, derived from the literature, that the average 30-days mortality is 3% after endovascular repair and 10% after open surgery justifies the design of a prospective study between endovascular therapy (50 patients (amendment n.5 - 9/07/2013) treated in 5 University hospitals with significant experience of the technique) and open repair (220 similar patients analyzed from the national database of the MOH).
In-hospital morbidity are similarly expected to be lower in the endovascular group. The investigators also wish to demonstrate that endovascular repair does not represent a significant overcost, as compared to open repair. The cost of the implantable medical device (IMD), of follow-up screening, and of eventual repeated interventions should be compensated by a reduced stay in intensive care unit ICU, and by a reduced in-hospital length of stay.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Aneurysm
Keywords
Aorta, Aneurysm, endovascular, stent-graft
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
49 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Endovascular therapy branched
Arm Type
Active Comparator
Arm Description
Endovascular therapy branched or fenestrated stent-graft
Arm Title
Open surgical repair
Arm Type
Other
Arm Description
Open surgical repair or aortic replacement with revascularization of visceral arteries
Intervention Type
Procedure
Intervention Name(s)
Endovascular aortic repair
Intervention Description
Insertion via bilateral femoral access, stent-graft deployment under fluoroscopic guidance, complementary stenting of visceral arteries, control angiogram
Intervention Type
Procedure
Intervention Name(s)
Open surgical repair
Intervention Description
Conventional therapy in France with the national database of the M.O.H.
Primary Outcome Measure Information:
Title
mortality
Time Frame
30-day postoperative
Secondary Outcome Measure Information:
Title
complications
Time Frame
30-day postoperative
Title
Length of Intensive Care Unit (ICU) stay
Time Frame
30-day postoperative
Title
Length of Hospital stay
Time Frame
30-day postoperative
Title
Overall cost
Time Frame
30-day postoperative
Title
Reinterventions
Time Frame
2-year follow up
Title
Global survival
Time Frame
2-year follow up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The following anatomical inclusion criteria must be met:
Absence of significant angulations (< 60°) of aorta or of iliac arteries
Absence of tight stenosis (>70%) of more than one target artery (renal or visceral artery to be perfused from the side holes of the stent-graft)
Diameter of target arteries over 5 mm
Iliac and femoral arteries allowing insertion of the delivery system (> 7 mm) or suitable for insertion of an access conduit
Exclusion Criteria:
Limited expected life expectancy
Emergency cases
Refuse to participate to the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Pierre Becquemin, PU-PH
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Henri Mondor Hospital
City
Creteil
ZIP/Postal Code
94010
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
20093051
Citation
Amiot S, Haulon S, Becquemin JP, Magnan PE, Lermusiaux P, Goueffic Y, Jean-Baptiste E, Cochennec F, Favre JP; Association Universitaire de Recherche en Chirurgie Vasculaire. Fenestrated endovascular grafting: the French multicentre experience. Eur J Vasc Endovasc Surg. 2010 May;39(5):537-44. doi: 10.1016/j.ejvs.2009.12.008. Epub 2010 Jan 25.
Results Reference
background
Links:
URL
http://www.vasculaire.mondor.aphp.fr
Description
PMID: 20093051
Learn more about this trial
Medical & Economical Evaluation of Fenestrated & Branched Stent-grafts to Treat Complex Thoracal Abdominal Aneurysms
We'll reach out to this number within 24 hrs